Mohawk Industries
MHK
$94.93
-5.00%
Mohawk Industries, Inc. is a leading global manufacturer of flooring products, including carpets, rugs, ceramic tile, laminate, wood, and luxury vinyl tile, operating within the Consumer Cyclical sector's Furnishings, Fixtures & Appliances industry. The company is a dominant market player with a diversified portfolio across its Global Ceramic, Flooring North America, and Flooring Rest of the World segments, leveraging its scale and vertical integration to serve both residential and commercial channels. The current investor narrative centers on navigating a cyclical downturn in the housing and renovation markets, with recent financial results showing significant pressure on profitability, leading to debates about the timing of a potential recovery and the company's ability to manage costs and maintain its competitive position amid softer demand.…
MHK
Mohawk Industries
$94.93
Investment Opinion: Should I buy MHK Today?
Rating: Hold. The core thesis is that while MHK appears deeply undervalued with a strong balance sheet, near-term fundamental headwinds are too severe to justify a Buy rating, and the lack of a visible cyclical catalyst suggests the stock could remain range-bound or drift lower.
The Hold rating is supported by four key data points: 1) The compelling forward P/E of 9.47x, which prices in a significant earnings recovery, 2) The robust liquidity position evidenced by a 2.19 current ratio and $616M in TTM FCF, 3) The stock's oversold technical condition, trading just 5% above its 52-week low, and 4) The high short ratio of 3.5, which sets up for a potential squeeze on any positive news. However, these are counterbalanced by the sharp Q4 profit decline to a 1.56% net margin and slowing revenue growth of 2.37%.
The two biggest risks invalidating a potential upgrade are 1) Further sequential declines in gross margin below 24%, and 2) A recession in the U.S. housing market causing revenue to turn negative. This Hold would upgrade to a Buy if the forward P/E compresses further toward 8x on sustained FCF generation, or if QoQ gross margins show stabilization or expansion. It would downgrade to Sell if quarterly net income turns negative or if the stock decisively breaks below the $94.56 support level on high volume. Valuation Verdict: The stock is fairly valued to slightly undervalued relative to its depressed earnings outlook but remains overvalued relative to near-term deteriorating fundamentals.
Sign up to view all
MHK 12-Month Price Forecast
MHK presents a high-risk, potentially high-reward opportunity for contrarian investors willing to bet on a cyclical turnaround. The valuation is compelling, and the financial strength is undeniable, but the fundamental momentum is sharply negative. The neutral stance reflects the balance between these forces, with the base case of a slow, grinding recovery being most probable. The stance would upgrade to bullish on concrete evidence of margin stabilization (e.g., two consecutive quarters of flat or improving gross margin) or a decisive break above the $115 resistance level. It would turn bearish if the company reports a quarterly loss or if housing starts data meaningfully disappoints for multiple months.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mohawk Industries's 12-month outlook, with a consensus price target around $123.41 and implied upside of +30.0% versus the current price.
Average Target
$123.41
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$76 - $123
Analyst target range
Analyst coverage for MHK appears limited, with only 3 analysts providing estimates for future EPS and revenue, and no consensus price target or recommendation data provided in the dataset, indicating insufficient analyst coverage for a robust consensus view. The lack of a clear target range and the minimal number of covering analysts typically points to this being a mid-cap stock with limited institutional research focus, which can contribute to higher volatility and less efficient price discovery; the recent institutional ratings from firms like RBC Capital and Truist Securities show a mix of 'Sector Perform' and 'Buy' ratings, but without quantified targets, the signal strength regarding future price appreciation remains unclear.
Bulls vs Bears: MHK Investment Factors
The investment debate for Mohawk Industries is a classic battle between deep cyclical value and deteriorating fundamentals. The bear case currently holds stronger near-term evidence, as reflected in the severe stock price decline, collapsing profitability, and decelerating revenue. However, the bull case is built on a compelling valuation premise, with the stock trading at a forward P/E of 9.5x and possessing a fortress balance sheet that provides time to wait for a cycle recovery. The single most important tension is the timing and magnitude of an earnings recovery. If management can stabilize margins and the housing market shows signs of life, the low valuation and high short interest could trigger a powerful rally. Conversely, if the downturn deepens or lasts longer than expected, the stock could remain depressed despite its apparent cheapness.
Bullish
- Strong Balance Sheet & Liquidity: The company maintains a robust current ratio of 2.19 and a moderate debt-to-equity ratio of 0.33, providing significant financial flexibility. This is further supported by substantial TTM free cash flow of $616.2 million, enabling it to weather the cyclical downturn, fund operations, and repurchase shares.
- Deeply Undervalued on Forward Earnings: The forward P/E ratio of 9.47x is exceptionally low, implying the market expects a significant earnings recovery. This valuation is a steep discount to the trailing P/E of 18.35x and suggests substantial upside if the company meets or exceeds the analyst-estimated EPS of $15.73.
- Oversold Technicals & High Short Interest: The stock trades near its 52-week low of $94.56, at just 21% of its 52-week range, indicating extreme oversold conditions. A high short ratio of 3.5 suggests significant bearish positioning, which could fuel a sharp short-covering rally on any positive fundamental catalyst or market rotation.
- Market Leader with Diversified Portfolio: As a leading global manufacturer with a diversified product line across ceramic, carpet, and vinyl flooring, Mohawk benefits from scale and vertical integration. This dominant position across residential and commercial channels provides a foundation for recovery when the housing and renovation cycle turns.
Bearish
- Severe Profitability Deterioration: Q4 2025 net income collapsed to $42 million (a 1.56% margin) from $108.9 million in Q3, and gross margin compressed to 24.57% from 25.45% in Q2. This sharp decline reflects intense cost pressures and operational inefficiencies amid weakening demand, raising concerns about management's ability to protect margins.
- Pronounced Cyclical Downtrend: The stock is in a severe downtrend, down 15.59% over 3 months and 6.12% over one year, significantly underperforming the SPY by -35.16% over the same period. This reflects persistent negative momentum and weak investor sentiment tied to the softening housing and renovation markets.
- Revenue Growth Deceleration: Q4 2025 revenue growth slowed to just 2.37% YoY, a marked deceleration from stronger prior quarters. This indicates mounting pressure from the demand environment, and without a clear catalyst for a near-term rebound, top-line stagnation could persist, limiting earnings recovery.
- Limited Analyst Coverage & Visibility: Only 3 analysts provide estimates for MHK, and no consensus price target is available, indicating limited institutional research focus. This can lead to higher volatility, less efficient price discovery, and a lack of clear catalysts to drive a re-rating, leaving the stock vulnerable to sentiment shifts.
MHK Technical Analysis
The stock is in a pronounced downtrend, evidenced by a 1-year price change of -6.12% and a more severe 3-month decline of -15.59%. Currently trading at $99.93, the price sits at approximately 21% of its 52-week range, positioned much closer to the 52-week low of $94.56 than the high of $143.13, suggesting the stock is deeply oversold and may represent a value opportunity, though it also signals persistent negative momentum and weak investor sentiment. Recent momentum shows a slight 1-month gain of 0.48%, which diverges from the longer-term downtrend and could indicate a potential stabilization or a dead-cat bounce; however, this minor uptick is dwarfed by the stock's severe underperformance relative to the SPY, with a relative strength of -9.50% over one month and -35.16% over one year, highlighting its significant weakness. Key technical support is firmly established at the 52-week low of $94.56, while resistance lies at the recent highs near $143.13; a decisive break below support could trigger further selling, whereas a sustained move above the downtrend line would be needed to signal a reversal, with the stock's high short ratio of 3.5 indicating substantial bearish positioning that could fuel a sharp rally on any positive catalyst.
Beta
—
—
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
$94-$143
Price range past year
Annual Return
-9.3%
Cumulative gain past year
| Period | MHK Return | S&P 500 |
|---|---|---|
| 1m | -1.9% | +9.5% |
| 3m | -23.9% | +4.1% |
| 6m | -14.1% | +6.0% |
| 1y | -9.3% | +26.7% |
| ytd | -13.3% | +5.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MHK Fundamental Analysis
Revenue growth has decelerated markedly, with Q4 2025 revenue of $2.70 billion representing only a 2.37% year-over-year increase, a significant slowdown from the stronger growth rates seen in prior quarters of 2025, indicating pressure from a softening end-market demand environment. Profitability has deteriorated sharply, with Q4 2025 net income plunging to $42 million (a net margin of 1.56%) from $108.9 million in Q3, and gross margin compressing to 24.57% from 25.45% in Q2, reflecting intense cost pressures and operational inefficiencies amid lower sales volumes. The balance sheet remains relatively healthy with a strong current ratio of 2.19 and a moderate debt-to-equity ratio of 0.33, while the company generated substantial free cash flow of $616.2 million over the trailing twelve months, providing ample liquidity to navigate the downturn, fund capital expenditures, and potentially engage in share repurchases, as evidenced by the $41.1 million in buybacks in Q4.
Quarterly Revenue
$2.7B
2025-12
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.24%
Latest Quarter
Free Cash Flow
$616200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MHK Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 18.35x, while the forward PE is significantly lower at 9.47x, indicating the market expects a substantial recovery in earnings over the next twelve months. Compared to sector averages, the stock's trailing PE of 18.35x and Price-to-Sales (PS) ratio of 0.63x appear modest, but a direct industry comparison is not available in the provided data; the low PS ratio suggests the market is assigning a discounted multiple to its sales, likely due to the depressed margin profile. Historically, the current trailing PE of 18.35x is below the stock's own historical range seen in recent quarters, which has fluctuated widely from negative values during losses to over 40x during periods of low earnings, suggesting the current valuation may not be demanding if earnings can stabilize and recover from the cyclical trough.
PE
18.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -3x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's sharply deteriorating profitability. The Q4 net margin of 1.56% is dangerously thin, and the sequential drop from a 3.9% margin in Q3 highlights extreme earnings volatility. While the balance sheet is strong, continued margin pressure could erode the substantial $616 million in TTM free cash flow, limiting financial flexibility. Revenue concentration in the cyclical U.S. housing market, which drives its largest segment, exposes the company to prolonged downturns in residential construction and remodeling, as evidenced by the slowing 2.37% revenue growth.
Market & Competitive Risks are dominated by valuation compression. The stock trades at a forward P/E of 9.5x, which may appear cheap but reflects deeply pessimistic earnings expectations. If the housing cycle remains weak, these multiples could fail to expand, trapping the stock at low levels. Competitive intensity in the flooring industry could pressure pricing further, while the stock's high beta nature (implied by its -35% relative strength vs. SPY) makes it highly sensitive to broader market sell-offs and rising interest rates, which directly impact its end markets.
The Worst-Case Scenario involves a protracted housing recession coupled with sustained inflation in raw material and labor costs, leading to further gross margin compression below 24%. This could push the company into quarterly losses, triggering debt covenant concerns and forcing a dividend suspension (though none exists) or asset sales. In this adverse scenario, the stock could realistically re-test and break below its 52-week low of $94.56, implying a further -5.4% downside from the current $99.93. A more severe drawdown towards the $80-$85 range (-15% to -20%) is possible if sentiment turns decisively negative, mirroring the stock's historical max drawdown of -31.77%.
FAQ
The key risks are: 1) Cyclical Demand Risk: Prolonged weakness in the housing and renovation markets, as signaled by slowing 2.37% revenue growth, could extend the earnings downturn. 2) Margin Compression Risk: Further deterioration from the current 24.57% gross margin, as seen in the sequential drop from Q2, could push the company toward breakeven or losses. 3) Macroeconomic Sensitivity: The stock's severe underperformance vs. the SPY (-35% over one year) shows high sensitivity to interest rates and economic sentiment. 4) Low Visibility Risk: Limited analyst coverage (only 3 analysts) contributes to volatility and inefficient price discovery, increasing the stock's vulnerability to sentiment shifts.
The 12-month forecast is a range of scenarios. The Base Case (60% probability) sees a slow recovery to a target range of $105-$120, driven by stabilized margins and a gradual housing market bottom. The Bull Case (25% probability) envisions a faster cyclical rebound propelling the stock toward $130-$143, its 52-week high. The Bear Case (15% probability) warns of further downside to $85-$95 if the downturn deepens. The most likely outcome is the Base Case, predicated on the assumption that the company's strong balance sheet allows it to weather the storm without a catastrophic earnings collapse, enabling a slow valuation recovery.
MHK appears statistically undervalued based on forward earnings, trading at a P/E of 9.47x compared to a trailing P/E of 18.35x. Its Price-to-Sales ratio of 0.63x is also low. However, this 'undervaluation' is justified by the severe cyclical pressure on its margins and growth. The market is pricing in a significant earnings recovery that is not yet visible in the reported results. Therefore, the stock is fairly valued relative to its near-term depressed fundamentals but could be deeply undervalued if the company successfully navigates the downturn and earnings rebound as analysts project.
MHK is a speculative buy for investors with a high risk tolerance and a long-term horizon. The stock offers compelling value with a forward P/E of 9.5x and a strong balance sheet, but it is squarely in the midst of a cyclical downturn with sharply deteriorating profits. For a conservative investor, it is not a good buy due to the lack of near-term catalysts and earnings visibility. For a contrarian value investor, the current price near 52-week lows may represent an attractive entry point to bet on a eventual housing recovery, but this requires patience and the acceptance of potential further downside towards the $95 support level.
MHK is unsuitable for short-term trading due to its high volatility, lack of near-term catalysts, and pronounced downtrend. It is a long-term, cyclical investment. Given the depth of the current downturn and the time required for housing markets to recover, investors should be prepared to hold for a minimum of 2-3 years to realize the potential value. The stock does not pay a dividend, so the entire return is dependent on capital appreciation from a cyclical turnaround. Its profile is best suited for a patient value allocation within a diversified portfolio.
